RT Journal Article
SR Electronic
T1 Neuromodulation through Brain Stimulation-assisted Cognitive Training in Patients with Post-Chemotherapy Cognitive Impairment (Neuromod-PCCI): Study Protocol of a Randomized Controlled Trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.04.22273380
DO 10.1101/2022.04.04.22273380
A1 Rocke, Merle
A1 Knochenhauer, Elena
A1 Thams, Friederike
A1 Antonenko, Daria
A1 Fromm, Anna Elisabeth
A1 Jansen, Nora
A1 Grittner, Ulrike
A1 Schmidt, Sein
A1 Brakemeier, Eva-Lotta
A1 Flöel, Agnes
YR 2022
UL http://medrxiv.org/content/early/2022/04/04/2022.04.04.22273380.abstract
AB Introduction Breast cancer is the most common form of cancer in women. A considerable number of women with breast cancer who have been treated with chemotherapy, subsequently develop neurological symptoms such as concentration and memory difficulties (also known as ‘chemobrain’). Currently, there are no validated therapeutic approaches available to treat these symptoms. Cognitive training holds the potential to counteract cognitive impairment. Combining cognitive training with concurrent transcranial direct current stimulation (tDCS) could enhance and maintain the effects of this training, potentially providing a new approach to treat post-chemotherapy cognitive impairment (PCCI). With this study, we aim to investigate the effects of multi-session tDCS over the left dorsolateral prefrontal cortex in combination with cognitive training on cognition and quality of life in women with PCCI.Methods and analysis The Neuromod-PCCI trial is a monocentric, randomized, double-blind, placebo-controlled study. Fifty-two women with PCCI after breast cancer therapy will receive a 3-week tDCS-assisted cognitive training with anodal tDCS over the left dorsolateral prefrontal cortex (target intervention), compared to cognitive training plus sham tDCS (control intervention). Cognitive training will consist of a letter updating task. Primary outcome will be the performance in an untrained task (n-back task) after training. In addition, feasibility, safety and tolerability, as well as quality of life and performance in additional untrained tasks will be investigated. A follow-up visit will be performed one month after intervention to assess possible long-term effects. In an exploratory approach, structural and functional magnetic resonance imaging (MRI) will be acquired before the intervention and at post-intervention to identify possible neural predictors for successful intervention.Ethics and dissemination Ethical approval was granted by the ethics committee of the University Medicine Greifswald (BB236/20). Results will be available through publications in peer-reviewed journals and presentations at national and international conferences.Trial registration This trial was prospectively registered at ClinicalTrials.gov (Identifier: NCT04817566, registered March 26, 2021).Strength and limitations of this study– This is the first randomized controlled trial to investigate the feasibility and effects of combined cognitive training and tDCS on cognitive outcomes and quality of life in patients with post-chemotherapy cognitive impairment– Results will help the development of treatment options for breast cancer patients with post-chemotherapy cognitive impairment– Results may not be generalizable to male cancer patients– Monocentric trial design may increase risk of biasCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04817566Funding StatementThe authors have not declared a specific grant for this research from any funding agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the ethics committee of the University Medicine Greifswald (BB236/20).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.